CD8B anticorps (AA 22-170)
Aperçu rapide pour CD8B anticorps (AA 22-170) (ABIN7171407)
Antigène
Voir toutes CD8B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 22-170
-
Réactivité croisée
- Humain
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Recombinant Human T-cell surface glycoprotein CD8 beta chain protein (22-170AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CD8B (CD8b Molecule (CD8B))
-
Autre désignation
- CD8B
-
Sujet
-
Background: Identifies cytotoxic/suppressor T-cells that interact with MHC class I bearing targets. CD8 is thought to play a role in the process of T-cell mediated killing.
Aliases: CD8b antigen antibody, CD8 antigen beta polypeptide 1 (p37) antibody, CD8 antigen beta polypeptide 1 antibody, CD8 beta antibody, CD8b antibody, CD8b molecule antibody, CD8B_HUMAN antibody, CD8B1 antibody, Leu2 antibody, Ly3 antibody, LYT3 antibody, MGC119115 antibody, P37 antibody, T cell surface glycoprotein CD8 beta chain antibody, T lymphocyte surface glycoprotein beta chain antibody, T-cell surface glycoprotein CD8 beta chain antibody
-
UniProt
- P10966
-
Pathways
- TCR Signaling
Antigène
-